P. Taslimi Et Al. , "Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia," International Journal of Biological Macromolecules , vol.119, pp.857-863, 2018
Taslimi, P. Et Al. 2018. Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia. International Journal of Biological Macromolecules , vol.119 , 857-863.
Taslimi, P., Aslan, H. E., Demir, Y., Oztaskin, N., MARAŞ, A., GÜLÇİN, İ., ... BEYDEMİR, Ş.(2018). Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia. International Journal of Biological Macromolecules , vol.119, 857-863.
Taslimi, Parham Et Al. "Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia," International Journal of Biological Macromolecules , vol.119, 857-863, 2018
Taslimi, Parham Et Al. "Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia." International Journal of Biological Macromolecules , vol.119, pp.857-863, 2018
Taslimi, P. Et Al. (2018) . "Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia." International Journal of Biological Macromolecules , vol.119, pp.857-863.
@article{article, author={Parham Taslimi Et Al. }, title={Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia}, journal={International Journal of Biological Macromolecules}, year=2018, pages={857-863} }